Benicar (generic: olmesartan medoxomil)
Brand name: Benicar, Benicar HCT (combination with hydrochlorothiazide)
---
1. What it is
- Drug class: Angiotensin II Receptor Blocker (ARB) – works by blocking the effects of angiotensin‑II, a hormone that narrows blood vessels.
- Form: Oral tablets (usually 5 mg, 10 mg, 20 mg, 40 mg; 20 mg/25 mg with HCT).
---
2. Primary Uses
| Condition | Typical indication | Common dose range |
|-----------|--------------------|-------------------|
| Primary hypertension | Lower high blood pressure | Start 20 mg daily → up to 40 mg daily (titrated by the clinician) |
| Hypertension + heart failure | Reduces mortality in heart‑failure patients | 10–20 mg daily → up to 40 mg daily |
| Hypertension + chronic kidney disease (stage 1‑3) | Reduces proteinuria, slows progression | 10–20 mg daily → up to 40 mg daily (monitor renal function) |
| Hypertension + diabetes | Helps protect kidneys and reduce cardiovascular risk | 10–20 mg daily → up to 40 mg daily |
Benicar HCT (olmesartan + hydrochlorothiazide) is used when a single tablet combination is preferred. The dose is usually 20 mg olmesartan/25 mg HCT, titrated upward as needed.
---
3. How to Take It
- Take once daily at the same time each day.
- Can be taken with or without food.
- Do not crush or chew the tablet—swallow whole.
- If you miss a dose, take it as soon as you remember unless it’s almost time for the next dose. Do not double‑dose.
---
4. Common Side Effects
| Symptom | Frequency | What to do |
|---------|-----------|------------|
| Dizziness or light‑headedness | 5–10 % | Stand up slowly, monitor BP; if severe, contact a clinician |
| Headache | 3–7 % | Over‑the‑counter analgesics (acetaminophen, ibuprofen) as needed |
| Hyperkalemia (high potassium) | <2 % | Monitor electrolytes if you’re on potassium‑sparing drugs |
| Gastro‑intestinal upset | 3–5 % | Take with food if upset |
| Fatigue | <5 % | Rest; report if worsening |
| Rare: Angioedema, severe rash | <0.1 % | Seek immediate medical care |
Note: Unlike ACE inhibitors, ARBs rarely cause cough or angioedema, but these can still occur.
---
5. Serious (but uncommon) Risks
| Condition | Why it matters | Prevention/Monitoring |
|-----------|----------------|-----------------------|
| Pregnancy (especially 1st trimester) | Fetal renal damage, death | Contraindicated. Discontinue and switch to a safer alternative (e.g., nifedipine, amlodipine). |
| Kidney impairment | Can worsen renal function and increase potassium | Check serum creatinine & potassium every 1–3 months after starting or dose change |
| Hyperkalemia | Can lead to life‑threatening cardiac arrhythmias | Avoid potassium‑sparing diuretics, spironolactone, NSAIDs; monitor serum potassium |
| Interaction with ACE inhibitors or ARBs | Dual blockade may cause hyperkalemia, renal failure | Avoid concurrent use unless under close monitoring (rarely recommended) |
| Interaction with aliskiren | Excessive BP drop, renal impairment | Avoid combination |
---
6. Drug Interactions to Watch
| Drug/Class | Interaction | Why it matters | How to mitigate |
|------------|-------------|----------------|-----------------|
| ACE inhibitors, ARBs | Additive effect | Hyperkalemia, renal impairment | Do not combine |
| Potassium‑sparing diuretics (e.g., spironolactone, triamterene) | ↑ potassium | Hyperkalemia | Avoid or monitor potassium |
| NSAIDs (e.g., ibuprofen, naproxen) | ↓ BP effect, ↑ renal risk | Renal impairment | Use with caution, monitor creatinine |
| Digoxin | ↑ digoxin levels | Cardiac arrhythmias | Monitor digoxin level if needed |
| Lithium | ↑ serum lithium | Toxicity | Monitor lithium level if co‑administered |
| Cimetidine | ↑ olmesartan absorption | Increased BP effect | Usually no major effect; monitor BP |
---
7. What to Tell Your Doctor
- All medications you’re taking, including OTC drugs, supplements, and herbal remedies.
- Recent lab results: kidney function, electrolytes, liver function.
- Medical history: kidney disease, heart failure, pregnancy status, diabetes.
- Any symptoms you notice after starting therapy (dizziness, swelling, rash, difficulty breathing).
---
8. Special Populations
| Population | Key Points |
|------------|------------|
| Pregnancy | Contraindicated after first trimester. If you’re pregnant, inform your clinician immediately. |
| Breastfeeding | Limited data; generally not recommended. |
| Elderly | Start at lower dose; monitor BP and renal function. |
| Children | Not approved for use. |
| Renal impairment | Dose adjustment may be needed; monitor creatinine and potassium. |
| Hepatic impairment | Usually safe; monitor liver enzymes. |
---
9. Storage
- Keep at room temperature (15–30 °C / 59–86 °F).
- Protect from moisture, heat, and light.
- Keep out of reach of children and pets.
---
10. Quick Reference: “Ask Your Doctor”
| Question | Why it matters |
|----------|----------------|
| What is my target blood pressure? | Helps tailor dose. |
| Can I take olmesartan with my other meds? | Avoid harmful interactions. |
| Should I keep a record of my BP readings? | Monitor effectiveness. |
| Will I need lab tests? | Check kidney function & electrolytes. |
| What if I miss a dose? | Avoid double‑dosing. |
---
Bottom Line
Benicar (olmesartan) is a widely used, effective ARB for hypertension and certain heart‑failure conditions. It’s generally well tolerated, but watch for dizziness, hyperkalemia, and interactions with other blood‑pressure or potassium‑altering drugs. Never use it during pregnancy. If you have any concerns or notice unusual symptoms, contact your healthcare provider promptly.